RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
NCT01719055
This study is recruiting at 12 US sites in 9 states, according to its ClinicalTrials.gov record last updated .
Summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use - and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pain
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Boston Scientific Corporation
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- Denver Back Pain Specialists · Greenwood Village, CO
Florida · 3
- Orlando Health Neuroscience Institute, Inc · Clermont, FL
- South Lake Pain Institute, Inc · Clermont, FL
- University of Florida Shands Hospital · Gainesville, FL
Louisiana · 2
- Ochsner Clinic Foundation · New Orleans, LA
- Willis-Knighton River Cities Clinical Research Center · Shreveport, LA
Massachusetts · 1
- Brigham and Women's Hospital · Boston, MA
New York · 1
- Montefiore Medical Center · The Bronx, NY
Oregon · 1
- Pacific Sports and Spine, LLC · Eugene, OR
Pennsylvania · 1
- Fox Chase Pain Management · Trevose, PA
South Carolina · 1
- PCPMG Clinical Research Unit, LLC · Greenville, SC
Texas · 1
- Institute of Precision Pain Medicine · Corpus Christi, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.